Caris Life Sciences

Medtech · Public

Comprehensive molecular tumor profiling platform that sequences and analyzes tumor DNA and RNA to identify mutations and guide cancer treatment selection

carislifesciences.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1822CARRTECH LLC——
1823RIO PHARMACEUTICALS, INC.——
1824iMacular Regeneration LLC——
1825Caris Life Sciences——
1826FLOWPOINT MEDICAL INC——
1827LF PRINTECH LLC——
1828APPLIED NANOSTRUCTURES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.